caa a22 4500 445315946 CHVBK 20180317142647.0 cr unu---uuuuu 170323e20110501xx s 000 0 eng 10.1007/s10552-011-9743-6 doi (NATIONALLICENCE)springer-10.1007/s10552-011-9743-6 Non-cancer mortality among people diagnosed with lymphohaematopoietic neoplasm in Australia [Elektronische Daten] [Peter Baade, Jill Royle, David Joske, Lin Fritschi] Objectives: There is some evidence that people diagnosed with cancer have increased risks of dying from other diseases. This may particularly be so for cancers such as the lymphohaematopoietic neoplasms (LHN) which are now managed more as chronic diseases than acute events. Methods: The non-cancer mortality of people diagnosed with LHN in Australia between 1982 and 2006 was compared to the mortality of the age- and sex-matched Australian population. Results: Australians diagnosed with LHN had about an 80% higher risk (SMR=1.82; 95% CI=1.79-1.85) of dying from a non-cancer cause of death than the general population, with this increased risk particularly evident in the first 3-12months after diagnosis. While the relative risk varied by LHN subtypes, all had an inflated relative risk. Despite younger patients having a lower absolute mortality risk, their relative mortality risk was particularly high; this decreased as age increased. The causes of death with the highest relative risks were infections and diseases of blood and blood-forming organs. Conclusions: The consistently increased risks of non-cancer causes of death compared to the general population for patients diagnosed with LHN highlight the importance that general practitioners and haematologists should bear in mind the patient's other medical conditions as well as the LHN diagnosis. Springer Science+Business Media B.V., 2011 Lymphohaematopoietic nationallicence Neoplasm nationallicence Non-cancer causes of death nationallicence Mortality nationallicence Survivorship nationallicence CHOP : Cyclophopsphamide/hydroxyadriamycin/oncovin/prednisolone nationallicence Baade Peter Viertel Centre for Research in Cancer Control, Cancer Council of Queensland, PO Box 201, 4001, Spring Hill, QLD, Australia aut Royle Jill Western Australian Institute for Medical Research, University of Western Australia, Perth, WA, Australia aut Joske David Department of Medicine, University of Western Australia, Perth, WA, Australia aut Fritschi Lin Western Australian Institute for Medical Research, University of Western Australia, Perth, WA, Australia aut Cancer Causes & Control Springer Netherlands 22/5(2011-05-01), 715-723 0957-5243 22:5<715 2011 22 10552 https://doi.org/10.1007/s10552-011-9743-6 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s10552-011-9743-6 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Baade Peter Viertel Centre for Research in Cancer Control, Cancer Council of Queensland, PO Box 201, 4001, Spring Hill, QLD, Australia aut NATIONALLICENCE 700 1- Royle Jill Western Australian Institute for Medical Research, University of Western Australia, Perth, WA, Australia aut NATIONALLICENCE 700 1- Joske David Department of Medicine, University of Western Australia, Perth, WA, Australia aut NATIONALLICENCE 700 1- Fritschi Lin Western Australian Institute for Medical Research, University of Western Australia, Perth, WA, Australia aut NATIONALLICENCE 773 0- Cancer Causes & Control Springer Netherlands 22/5(2011-05-01), 715-723 0957-5243 22:5<715 2011 22 10552 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer